CD163 and neoplasm: As a relatively specific marker for M2 macrophages, CD163 has been reported to be closely correlated with some EBV-associated tumours, such as classical Hodgkin's lymphoma 47, diffuse large B-cell lymphoma 48 and NPC 49.